Abstract. One of the determinants of cellular responsiveness to glucocorticoid hormone is the concentration of the receptor protein. It is well-known that cellular receptor levels are down-regulated by the cognate ligands, but the biological significance of this homologous down-regulation of the receptor has not yet been completely understood. We showed that in human histiocytic lymphoma cell line U937 the cellular glucocorticoid receptor was homologously down-regulated by means of both ligand binding and Western immunoblot experiments. Reduction of the receptor was saturable, and the receptor levels tended to return to the levels before treatment after 3-day culture in the presence of the hormone. Next, using the cells which were pretreated with the hormone for 0 to 3 days, hormonal inducibility of the transiently-transfected reporter gene and the inhibitory effect of the hormone on cellular 3-0-methyl glucose uptake were determined.
GLUCOCORTICOID
hormones exert their regulatory effects by binding to the intracellular protein glucocorticoid receptor (GR), a member of the superfamily of nuclear receptors [1] . In response to binding of the ligand, these proteins modulate target gene transcription in either a positive or negative manner [2] [3] [4] . On the binding hormone, GR undergoes a conformational change (termed receptor activation) involving dissociation of inhibitory proteins; i.e. the 90 kDa heat shock protein [2] [3] [4] . The activated hormone-receptor complex translocates to the cell nucleus and binds to the target DNA sequences termed glucocorticoid response elements (GREs) [2] [3] [4] . Although GR has been demonstrated to interact functionally with various ubiquitous transcription factors [ref. 5 , and references therein], it is not clear how the receptor communicates with the basal transcription machinery.
The pivotal role that the receptor plays in hormone action is underscored by the observation that development of the steroid resistant state is virtu-ally always accompanied by either mutation of the receptor [ref. 6 , and references therein] or decreased receptor content [7] . A direct correlation between the number of GRs and cellular responsiveness to the hormone has been documented in a variety of cell lines [8] [9] [10] [11] as well as in human subjects [12] [13] [14] [15] [16] [17] [18] . On the other hand, the concentration of GR varies even within a given tissue; receptor levels may fluctuate with changes in the cell cycle [19] , during aging [20] , and in response to the hormone [reviewed in ref. 21 ]. When exposed to agonistic ligands, cellular GR was shown to decrease by means of ligand-binding assay [22] and immunoblotting analysis [23] . This phenomenon, termed down-regulation, could be frequently encountered in human since the clinical use of glucocorticoids is extensive and usually continuous. It has recently been shown that the introduction of GR antisense RNA into cells results in decreased cellular response to glucocorticoids, most likely through blocking cellular receptor mRNA processing and/ or translation and a subsequent decrease in cellular GR [24] . More recent studies have shown that the homologous down-regulation of stably transfected human GR is closely related with hormone responsiveness in Chinese hamster ovary cells [25] . However, this down-modulation of hormone sensitivity in receptor-depleted cells has not yet been clearly documented in native, hormone-treated cells. We therefore examined whether hormone sensitivity substantially alters when cells are exposed to agonistic ligands and receptor levels were substantially down-regulated. Here we report that human U937 cells show homologous down-regulation of GR levels with concomitant alteration in cellular responsiveness to the hormone. significant alterations in Kd value was apparent (Table 1) . To further confirm this cyclic alteration in cellular GR content, GR protein immunoreactivity in whole cell extracts was also determined after treatment of U937 cells with the hormone. As shown in Fig. 2 , we detected major 94 kDa as well as minor 91 kDa protein bands, both of which specifically interacted with anti-GR antibodies. A similar observation was already reported when this antibody was used [23] , but the relationship of the 91 kDa protein to the 94 kDa GR is unknown [23] . After treatment with dexamethasone, both of these immunogenic bands were reduced in signal intensity (Fig. 2) . Densitometric analysis revealed that the GR protein level in whole cell extracts had declined to 52, 27, 40% of the level found in untreated cells, after 1, 2 and 3 days' treatment with dexamethasone, respectively. These results of immunoblot analysis, including partial restoration in GR contents, were almost comparable with those of the Iigand binding assay (see also Table 1 ).
Materials and Methods

Chemicals
Down-modulation of GR function after hormone treatment
Since it is generally believed that the levels of trans-acting factors coordinately influence the transcription efficiency of their target genes [30] , we investigated the alteration in glucocorticoid-inducible gene expression after causing a homologous down-regulation of GR. Treatment with dexamethasone, as shown above, resulted in a time-dependent alteration in cellular GR content (Table 1) levels affects hormonal sensitivity in vivo. Here we showed that in human histiocytic lymphoma cell line U937 both dexamethasone-binding capacity and GR immunoreactivity decreased after treatment with dexamethasone and this down-regulation of the native receptor resulted in down-modulation of cellular sensitivity to the hormone.
In the present study, GR down-regulation was observed after 24 h of hormone treatment, lasting for another 24 h, and restoration of hormone binding capacity and GR protein levels was shown in the cells treated with the hormone for 3 days. This cyclic pattern of GR levels after hormone treatment was also reported previously [23, 32] , but the reason for which remains unknown [23] . There could be, among others, at least three possibilities.
First, prolonged hormone treatment might eliminate hormone responsive cells by means of, for example, apoptosis [33] , and result in relative dominance of the population composed of unresponsive cells. Down-regulation is known to be mediated by the functional GR, so that resistant cells are expected to be less down-regulated in GR levels [11] . However, our data strongly argue against this hypothesis, since cellular responsiveness to the hormone also tended to be restored in parallel with the amount of GR. Second, tachyphylaxis may also occur in a negative regulatory mechanism for cellular receptor levels through, for example, a decrease in the recruitment of the cellular negative regulator of GR gene expression [34] . At this moment, however, cellular metabolism of such a protein(s) is not known. Third, certain steroidmetabolizing enzyme(s) might be induced by hormone treatment, and could inactivate dexamethasone in the cells. Further studies will clearly be needed to explain this cyclic pattern of GR regulation.
The close relationship between receptor content and cellular sensitivity has been postulated from various experiments in which intracellular receptor content was manipulated both in vivo and in vitro (See "Introduction").
In the case of receptor down-regulation, relatively direct evidence of a receptor content-function relationship was presented by means of the introduction of GR antisense RNA into cells [24] and homologous down-regulation in a Chinese hamster ovary derived cell line containing stably transfected human GR cDNA [25] . On the other hand, our results are the first evidence that proved the close relationship between down-regulation of the native receptor and hormonal sensitivity, at both transcriptional and, most possibly, posttranscriptional levels, induction of the MMTV promoter, and glucose uptake inhibition, respectively.
In the MMTV promoter, it is believed that GR protein binds to target sites on the promoter DNA and activates gene expression [3] . Therefore, a relative decrease in MMTV promoter activation in GR down-regulated cells may simply be due to a relative deficiency in positive transacting factor GR. On the other hand, GR has recently been shown to regulate various genes through protein-protein interaction [51, and negative gene regulation by GR is suggested to involve formation of a novel GR complex which contains three GR subunits [35] . Analysis of various endogenous gene expression in GR-down regulated cells, therefore, would provide more detailed molecular information to assist the understanding of the biological significance of GR down-regulation.
The glucocorticoid-induced decrease in the transport of 3-O-MG in thymocytes or human mononuclear leukocytes is known to be GR-mediated [18, and references therein], and has a close correlation with the GR level [18, 36, 37] . In the present study we showed that this glucose uptake inhibition effect varied in parallel with cellular GR content when the cells were pretreated with dexamethasone. Although the precise underlying mechanism of uptake inhibition by the hormone remains unknown [38, 39] , this close relationship may, at least in part, directly implicate the clinical significance of the GR down-regulation, since glucose uptake inhibition is considered to be strongly linked to the lipolytic action of glucocorticoids in adipose tissues [40] [41] [42] .
In summary, U937 cells revealed down-regulation of GR, and moreover, down-modulation of cellular sensitivity to the hormone, when cells were cultured in the presence of the hormone.
It is interesting that the GR level, as well as hormone responsiveness, tended to be restored thereafter. Molecular understanding of cellular control of hormonal sensitivity awaits further studies, but the results presented here suggest that negative control of the receptor level may be pivotal in the attenuation of excessive hormone effects in vivo.
